Australian and New Zealand Urogenital and Prostate Cancer Trials Group - Academic Profile

Publications

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman , Nathan Lawrentschuk , Roslyn J. Francis +23 more

2020 The Lancet 1768 citations

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Ian D. Davis , Andrew Martin , Martin R. Stockler +29 more

Enzalutamide was associated with significantly longer progression-free and overall survival than standard care in men with metastatic, hormone-sensitive prostate cancer receivin...

2019 New England Journal of Medicine 1481 citations

Affiliated Researchers

Scott Williams

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Margaret McJannett

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Institution Info

Type: nonprofit
Country: AU
Publications: 2
Citations: 3,249

External Links

Identifiers

ROR: https://ror.org/05jtex909